Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription 27.08.2018 1 Am J Respir Crit Care Med 3 Antimicrob Agents Chemother 1 BMJ 1 Eur J Clin Microbiol Infect Dis 1 Eur Respir J 1 J Clin Microbiol 1 J Infect 1 Lancet 2 Lancet HIV 1 PLoS Med 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Respir Crit Care Med

1. ELKINGTON PT, Bateman AC, Thomas GJ, Ottensmeier CH, et al
   Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.
   Am J Respir Crit Care Med. 2018 Aug 24. doi: 10.1164/rccm.201807-1250.
   PubMed     Text format    
   
   

   
   Antimicrob Agents Chemother

2. LUPIEN A, Vocat A, Foo CS, Blattes E, et al
   An optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone Macozinone (PBTZ169).
   Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.00840.
   PubMed     Text format     Abstract available
   
   
3. CAO R, Teskey G, Islamoglu H, Abrahem R, et al
   Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
   Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01132.
   PubMed     Text format     Abstract available
   
   
4. ALFARISI O, Mave V, Gaikwad S, Sahasrabudhe T, et al
   The effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment.
   Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01383.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

5. BEHR MA, Edelstein PH, Ramakrishnan L
   Revisiting the timetable of tuberculosis.
   BMJ. 2018;362:k2738.
   PubMed     Text format    
   
   

   
   Eur J Clin Microbiol Infect Dis

6. DE GEYTER D, Cnudde D, Van der Beken M, Autaers D, et al
   Evaluation of the Copan Myco-TB kit for the decontamination of respiratory samples for the detection of Mycobacteria.
   Eur J Clin Microbiol Infect Dis. 2018;37:711-714.
   PubMed     Text format     Abstract available
   
   

   
   Eur Respir J

7. KIK SV, Schumacher S, Maria Cirillo D, Churchyard G, et al
   An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease.
   Eur Respir J. 2018 Aug 23. pii: 13993003.00946-2018.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Microbiol

8. RYU MR, Park MS, Cho EH, Jung CW, et al
   Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in the Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
   J Clin Microbiol. 2018 Aug 22. pii: JCM.00438-18. doi: 10.1128/JCM.00438.
   PubMed     Text format     Abstract available
   
   

   
   J Infect

9. UHEL F, Corvaisier G, Poinsignon Y, Chirouze C, et al
   Mycobacterium tuberculosis prosthetic joint infections: a case series and literature review.
   J Infect. 2018 Aug 20. pii: S0163-4453(18)30253.
   PubMed     Text format     Abstract available
   
   

   
   Lancet

10. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    PubMed     Text format    
    
    

    
    Lancet HIV

11. HANRAHAN C, Dowdy D
    Chest X-ray for tuberculosis preventive therapy: use caution.
    Lancet HIV. 2018 Aug 20. pii: S2352-3018(18)30213.
    PubMed     Text format    
    
    
12. HAMADA Y, Lujan J, Schenkel K, Ford N, et al
    Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis.
    Lancet HIV. 2018 Aug 20. pii: S2352-3018(18)30137.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

13. MCINTOSH AI, Jenkins HE, White LF, Barnard M, et al
    Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysis.
    PLoS Med. 2018;15:e1002638.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

14. PEREA RAZO CA, Rodriguez Hernandez E, Ponce SIR, Milian Suazo F, et al
    Molecular epidemiology of cattle tuberculosis in Mexico through whole-genome sequencing and spoligotyping.
    PLoS One. 2018;13:e0201981.
    PubMed     Text format     Abstract available
    
    
15. ANAND T, Kishore J, Isaakidis P, Gupte HA, et al
    Integrating screening for non-communicable diseases and their risk factors in routine tuberculosis care in Delhi, India: A mixed-methods study.
    PLoS One. 2018;13:e0202256.
    PubMed     Text format     Abstract available
    
    
16. CHINGONZOH R, Manesen MR, Madlavu MJ, Sopiseka N, et al
    Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    PLoS One. 2018;13:e0202469.
    PubMed     Text format     Abstract available
    
    
17. AVONG YK, Jatau B, Gurumnaan R, Danat N, et al
    Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
    PLoS One. 2018;13:e0200810.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

18. TIWARI S, van Tonder AJ, Vilcheze C, Mendes V, et al
    Arginine-deprivation-induced oxidative damage sterilizes Mycobacterium tuberculosis.
    Proc Natl Acad Sci U S A. 2018 Aug 24. pii: 1808874115.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: